News|Videos|February 28, 2025
What ‘Going Wild’ on Healthcare Could Mean: The Early Days of Trump Healthcare
Three Washington, D.C., healthcare policy experts and the former chief of staff of HHS dive into the healthcare politics and policies of the new administration: RFK Jr.’s confirmation hearings; the future of IRA drug price negotiations and PBM reform; Medicare Advantage under the new administration; DOGE cuts at HHS; and ant-DEI and the social determinants of health.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Jascayd gets second FDA approval, this time for progressive pulmonary fibrosis
2
2025 FDA added indications to dermatologic medications
3
What NCCN’s next CMO sees ahead for cancer guidelines, access and innovation
4
5 developments in the treatment of prurgio nodularis in 2025
5
















































